Praxis Precision Medicines, Inc.

• Praxis Precision Medicines, Inc. Estimates – NASDAQ:PRAX
  TradingView · 23 Oct 2026
• PRAX stock: UBS starts coverage of Praxis Precision Medicines stock at USD 706.00
  AD HOC NEWS · 23 Oct 2026
• Praxis Precision Medicines Rises as Investors Revisit Late-2026 FDA Catalysts
  Quiver Quantitative · 19 Oct 2026
• H.C. Wainwright keeps USD 1,201 target for Praxis Precision Medicines stock
  ad-hoc-news.de · 15 Oct 2026
• BTIG raised its target for Praxis Precision Medicines stock to USD 826
  ad-hoc-news.de · 14 Oct 2026
• Needham raises target to $575 after Praxis seizure drug BTD
  scanx.trade · 07 Oct 2026
• Praxis Precision Q2FY26 Results: Operating expenses rise to $96.9 million
  scanx.trade · 06 Oct 2026
• Praxis Precision Medicine Q2 2026 Earnings Call Transcript
  Benzinga · 06 Oct 2026
• Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  The Manila Times · 03 Oct 2026
• Praxis Precision Medicine options signal ahead of two FDA decisions
  Investing.com · 30 Sep 2026
• H.C. Wainwright reiterates Praxis Precision stock rating on pipeline potential
  Investing.com · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →